Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
复制标题
DOI:
10.1016/j.acra.2018.02.010
复制
发表时间:
2018-11
影响因子:
4.8
通讯作者:
Pan L
中科院分区:
文献类型:
--
作者:
Jacobs MA;Macura KJ;Zaheer A;Antonarakis ES;Stearns V;Wolff AC;Feiweier T;Kamel IR;Wahl RL;Pan L
The purpose of this study was to investigate the use of multiparametric, whole-body, diffusion-weighted imaging (WB-DWI) and Apparent Diffusion Coefficient (ADC) maps with T2-weighted MRI at 3T for the detection and monitoring of metastatic disease in patients. Fifty-four participants (32 healthy subjects and 22 patients) were scanned with WB-DWI methods using a 3T MRI scanner. Axial, sagittal, or coronal fat-suppressed T2-weighted (T2WI), T1-weighted(T1WI), and DWI images were acquired. Total MRI acquisition and set up time was approximately 45 minutes. Metastatic disease on MRI was confirmed based on T2WI characteristics. The number of lesions were established on Computed Tomography (CT) or PET/CT. Whole-body ADC maps and T2WI were constructed and region-of-interests (ROIs) were drawn in normal and abnormal-appearing tissue for quantitative analysis. Statistical analysis was performed using a paired t-tests and p<0.05 was considered statistically significant. There were 91 metastatic lesions detected from the CT or PET/CT with a missed recurrent lesion in the prostate. Multiparametric WB-MRI had excellent sensitivity (96%) for detection of metastatic lesions compared to CT. ADC map values and the ADC ratio in metastatic bone lesions were significantly increased (p<0.05) compared to normal bone. In soft tissue, ADC map values and ratios in metastatic lesions were decreased compared to normal soft tissue. We have demonstrated that multiparametric WB-MRI is feasible for oncologic staging to identify bony and visceral metastasis in breast, prostate, pancreatic, and colorectal cancers. WB-MRI can be tailored to fit the patient, such that an “individualized patient sequence” can be developed for a comprehensive evaluation for staging and response during treatment.
登录
查看更多内容
影响因子:
82.9
作者:
Judenhofer, Martin S.;Wehrl, Hans F.;Pichler, Bernd J.
通讯作者:
Pichler, Bernd J.
影响因子:
4.8
作者:
Chen, XM;Moore, MO;Livingston, RB
通讯作者:
Livingston, RB
影响因子:
3.8
作者:
Jacobs, Michael A.;Ouwerkerk, Ronald;Stearns, Vered
通讯作者:
Stearns, Vered
影响因子:
5
作者:
Hergaden, G;O'Connell, M;Eustace, S
通讯作者:
Eustace, S
影响因子:
2.1
作者:
Axelsen, M. B.;Eshed, I.;Pedersen, S. J.
通讯作者:
Pedersen, S. J.